Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Enveric Biosciences Inc (NQ: ENVB )

2.850 -0.130 (-4.36%)
Streaming Delayed Price Updated: 3:59 PM EST, Feb 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 27,202
Open 3.000
Bid (Size) 2.830 (2)
Ask (Size) 3.200 (1)
Prev. Close 2.980
Today's Range 2.850 - 3.014
52wk Range 1.570 - 34.33
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
The 7 Most Promising Psychedelic Stocks to Buy in February
These psychedelics stocks to buy belong to pre-revenue firms which could potentially blow-up in line with the burgeoning sector. 
Via InvestorPlace
Enveric Biosciences to Present at the BIO CEO & Investor Conference
From Enveric Biosciences
Via Business Wire

Performance

YTD
+23.91%
+23.91%
1 Month
+9.20%
+9.20%
3 Month
+0.71%
+0.71%
6 Month
-53.96%
-53.96%
1 Year
-90.91%
-90.91%

More News

Read More
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Enveric Biosciences to Present at the 6th Annual Neuroscience Innovation Forum and Biotech Showcase during "J.P. Morgan Health Care Week 2023"
From Enveric Biosciences
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Enveric Biosciences Announces Confidential Submission of Registration Statement for the Spin-off of its Cannabinoid Business to Shareholders
From Enveric Biosciences
Via Business Wire
Enveric Biosciences to Participate in A.G.P.’s Virtual Biotech Conference
From Enveric Biosciences
Via Business Wire
Enveric Biosciences to Participate in Wonderland: Miami on November 3-5, 2022
From Enveric Biosciences
Via Business Wire
15 Global Psychedelics Executives To Keep An Eye On In 2022
Via Benzinga
Enveric Biosciences Advances Lead Candidate for the Treatment of Anxiety Disorders to IND-Enabling Studies
From Enveric Biosciences Inc.
Via Business Wire
Enveric Biosciences Announces Poster Presentations of Lead Programs at the 2022 International Neurology & Brain Disorders Conference
From Enveric Biosciences
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Psychedelics May Make People Less Afraid of Death
Via FinancialNewsMedia
Topics Supply Chain
Exposures Supply Chain
Enveric Biosciences to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022
From Enveric Biosciences, Inc.
Via Business Wire
World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them
Via Benzinga
7 Psychedelics Stocks to Buy for a Big Drug Boom
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
7 Short-Squeeze Stocks to Put on Your Must-Watch List
Via InvestorPlace
Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression
Via FinancialNewsMedia
Topics Supply Chain
Exposures Supply Chain
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday
Via Benzinga
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Why Is Yellow Trading Higher By 33%: Here Are 48 Stocks Moving Premarket
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.